To validate the overexpression of PUS7 in OV rather than normal samples, an Oncomine analysis was performed on ovarian cancer with different pathological types, and found that the PUS7 expression is highly elevated in OV samples with fold change >1 and p < 0.05 (as presented in Figure 3A,B and Table 1). Here, PUS7 is linked to ovarian cancer.